Advertisement

Pharmacy World and Science

, Volume 17, Issue 4, pp 103–112 | Cite as

Traditional Chinese herbal medicine

  • You-Ping Zhu
  • Herman J. Woerdenbag
Reviews

Abstract

Herbal medicine, acupuncture and moxibustion, and massage are the three major constituent parts of traditional Chinese medicine. Although acupuncture is well known in many Western countries, Chinese herbal medicine, the most important part of traditional Chinese medicine, is less well known in the West. This article gives a brief introduction to the written history, theory, and teaching of Chinese herbal medicine in China. It also describes modern scientific research into and the quality control of Chinese herbal medicines in China. Some examples of how new drugs derived from Chinese herbs have been developed on the basis of traditional therapeutic experience are presented. Finally, the situation of Chinese herbal medicine in the West is discussed.

Keywords

Books Drug screening Drugs, Chinese herbal Education History of medicine Medicine, Chinese traditional Pharmacology Quality control Research 
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Zhang EQ. Prescriptions of traditional Chinese medicine. Shanghai: Shanghai TCM College Press, 1990:10–6.Google Scholar
  2. 2.
    Bensky D, Barolet R. Chinese herbal medicine: formulas and strategies. Seattle: Eastland Press, 1990:14–5.Google Scholar
  3. 3.
    Zhu Y-P. Development of Chinese materia medica in perspective. In: Su ZW, Qiao CZ, editors. Pharmacognosy. Shanghai: Shanghai Medical University Press, 1989:4–9.Google Scholar
  4. 4.
    Huang SB, Chen CM. Herbology. Nanjing: NIT Press, 1988: 43–5.Google Scholar
  5. 5.
    Maciocia G. The foundations of Chinese medicine. Edinburgh: Churchill Livingstone, 1989:1–528.Google Scholar
  6. 6.
    Maciocia G. The practice of Chinese medicine. Edinburgh: Churchill Livingstone, 1994:1–484.Google Scholar
  7. 7.
    Tang W, Eisenbrand G. Chinese drugs of plant origin — chemistry, pharmacology and use in traditional and modern medicine. Berlin: Springer-Verlag, 1992:1–105.Google Scholar
  8. 8.
    Huang KC. The pharmacology of Chinese herbs. Boca Raton: CRC Press, 1993:229–32, 359.Google Scholar
  9. 9.
    Weiss RF. Herbal medicine. Gothenburg: Arcanum, 1988:218–9, 343–4.Google Scholar
  10. 10.
    Woerdenbag HJ, de Smet PAGM, Scheffer JJC. Plantaardige geneesmiddelen in medisch-farmaceutisch perspectief [Herbal remedies in medical-pharmaceutical perspective]. Pharm Weekbl 1993;128(6):164–77.Google Scholar
  11. 11.
    Trigg PI. Qinghaosu (Artemisinin) as an antimalarial drug. In: Wagner H, Hikino H, Farnsworth NR, editors. Economic and medicinal plant research. Vol. 3. London: Academic Press, 1989:19–55.Google Scholar
  12. 12.
    Woerdenbag HJ, Pras N, van Uden W, Wallaart TE, Beekman AC, Lugt CB. Progress in the research of artemisinin-related antimalarials:an update. Pharm World Sci 1994;16(4):169–80.PubMedGoogle Scholar
  13. 13.
    Liang X-T, Yu DQ, Wu WL, Deng HC. The structure of Yingzhaosu A. Acta Chim Sin 1979;37:215–30.Google Scholar
  14. 14.
    Che C-T. Plants as a source of potential antiviral agents. In: Wagner H, Farnsworth NR, editors. Economic and medicinal plant research. Vol. 5. London: Academic Press, 1991:166–251.Google Scholar
  15. 15.
    Woerdenbag HJ Gossypol. In: de Smet PAGM, Keller K, Hänsel R, Chandler RF, editors. Adverse effects of herbal drugs. Vol. 2. Berlin: Springer-Verlag, 1993:195–208.Google Scholar
  16. 16.
    Wang Y, Qian RQ, Gu ZW, Jin SW, Zhang LQ, Xia ZX, et al. Scientific evaluation of Tian Hua Feng — history, chemistry and application. Pure Appl Chem 1986;58:789–98.Google Scholar
  17. 17.
    Wu RS, Zhang SM, Ma JW. Rat model of passive lung anaphylaxis induced by trichosanthin. Acta Pharmacol Sin 1985;6:68–71.Google Scholar
  18. 18.
    Lednicer D, Sander KM. Plants and other organisms as a source of anti-human immunodeficiency virus (HIV) drugs. In: Wagner H, Farnsworth NR, editors. Economic and medicinal plant research. Vol. 5. London: Academic Press, 1991: 1–20.Google Scholar
  19. 19.
    Han R. Recent progress on the studies of anticancer traditional Chinese herbs. In: Xu GJ, Ming ZD, editors. Proceedings of 1st International Symposium on Chinese Materia Medica, Nanjing, 1990:14–2.Google Scholar
  20. 20.
    Han R. Highlight on the studies of anticancer drugs from plants in China. Stem Cells 1994;12:53–63.PubMedGoogle Scholar
  21. 21.
    Wan JH, You YC, Mi JX, Ying HG. Effect of indirubin on hemopoietic cell production. Acta Pharmacol Sin 1981;2: 241–4.Google Scholar
  22. 22.
    Wu KM, Zhang MY, Fang Z, Huang L. Potential antileukaemic agents, synthesis of derivatives of indirubin, indigo, and isoindigotin. Acta Pharm Sin 1985;20:821–6.Google Scholar
  23. 23.
    Zhou JH, Wang JM. Chinese herbal pharmacology. Shanghai: Shanghai Science & Technology Publisher, 1985: 30.Google Scholar
  24. 24.
    Han GY, Shen QH. Research and development of the active constituents of medicinal herbs. Hangzhou: Hangzhou University Press, 1991:34–5,43–4,53–4.Google Scholar
  25. 25.
    Wang YS, editor. The pharmacology and applications of Chinese materia medica. Beijing: People's Health Publisher, 1983:119–28,177–86.Google Scholar
  26. 26.
    Shen M-L. The contribution of traditional Chinese medicine to modern pharmacology. Trends Pharmacol Sci 1983;4: 496–50.Google Scholar
  27. 27.
    Fan SF. Chinese medicinal herbs used to treat heart diseases. Trends Pharmacol Sci 1983;4:208–10.Google Scholar
  28. 28.
    Zhang RW, Tang XC, Han YY, Sang GW, Zhang YD, Ma YX, et al. Drug evaluation of huperzine-A in the treatment of senile memory disorders. Acta Pharmacol Sin 1991;12:250–2.Google Scholar
  29. 29.
    Zhu Y-P, Qiao CZ. Radix aconiti et radix aconiti lateralis preparata. In: Su ZW, Qiao CZ, editors. Pharmacognosy. Shanghai: Shanghai Medical University Press 1989:109–1.Google Scholar
  30. 30.
    Hsu H-Y. A study of some commonly used medicinal herbs. In: Chang HM, Yeung HW, Tso W-W, Koo A, editors. Advances in Chinese medicinal materials research. Singapore: World Scientific Publ. Co., 1985:61–72.Google Scholar
  31. 31.
    The Pharmacopoeia Commission of the Ministry of Public Health. Pharmacopoeia of the People's Republic of China, 1990 edition, Vol. 1. Beijing: People's Health Publisher and Chemical Industries Publisher, 1990:27–8, 161−2.Google Scholar
  32. 32.
    Zhu Y-P, Qiao CZ. The processing of Chinese materia medica. In: Su ZW, Qiao CZ, editors. Pharmacognosy. Shanghai: Shanghai Medical University Press 1989:77–88.Google Scholar
  33. 33.
    Zhu Y-P, Qiao CZ, Su ZW, Li CH. Quality evaluation study on Semen Armeniaca Amarum. J 2nd Mil Med Univ 1991;12:90–2.Google Scholar
  34. 34.
    Wu SH. Jiangsu. J Trad Chin Med 1964;(10):1.Google Scholar
  35. 35.
    De Smet PAGM. Toxicological outlook on the quality assurance of herbal remedies. In: de Smet PAGM, Keller K, Hänsel R, Chandler RF, editors. Adverse effects of herbal drugs. Vol. 1. Berlin: Springer-Verlag, 1992:1–72.Google Scholar
  36. 36.
    Graham-Brown R. Toxicity of Chinese herbal remedies. Lancet 1992;340:673–4.PubMedGoogle Scholar
  37. 37.
    Rustin MHA, Atherton DJ. Toxicity of Chinese herbal remedies. Lancet 1992;340:674.Google Scholar
  38. 38.
    Perharic-Walton L, Murray V. Toxicity of Chinese herbal remedies. Lancet 1992;340:674.Google Scholar
  39. 39.
    Vanherweghen J-L, Depierreux M, Tielemans C, Abramowicz D, Dratwa M, Jadoul M, et al. Rapidly progressive interstitial renal fibrosis in young women: association with a slimming regimen including Chinese herbs. Lancet 1993;341:387–91.PubMedGoogle Scholar
  40. 40.
    Vanhaelen M, Vanhaelen-Feastre R, But P, Vanherweghen J-L. Identification of aristolochic acid in Chinese herbs. Lancet 1994, 343:174.Google Scholar
  41. 41.
    Farnsworth NR, Akerele O, Bingel AS, Soejarto DD, Guo Z. Medicinal plants in therapy. Bull WHO 1985;63:965–81.PubMedGoogle Scholar
  42. 42.
    Ding GS. Traditional Chinese medicine and modern pharmacology. Int J Pharm 1987;1:11–5.Google Scholar
  43. 43.
    Anonymous. Pharmaceuticals from plants: great potential, few funds [editorial]. Lancet 1994;343:1513–5.Google Scholar
  44. 44.
    Harper JI, Yang S-L, Evans AT, Evans FJ, Phillipson JD. Chinese herbs for eczema. Lancet 1990;335:759.PubMedGoogle Scholar
  45. 45.
    Phillipson JD. Traditional medicine treatment of eczema: experience as basis for scientific acceptance. Eur Phytotelegram 1994;6:33–40.Google Scholar
  46. 46.
    Sheenan MP, Rustin MHA, Atherton DJ, Buckley C, Harris DJ, Brostoff J, et al. Efficacy of traditional Chinese herbal therapy in adults atopic dermatitis: results of a double-blind placebo-controlled study. Lancet 1992;340:13–7.PubMedGoogle Scholar
  47. 47.
    Wagner H, Norr H, Winterhoff H. Plant adaptogens. Phytomedicine 1994;1:63–76.Google Scholar
  48. 48.
    De Smet PAGM. Legislatory outlook on the safety of herbal remedies. In: de Smet PAGM, Keller K, Hänsel R, Chandler RF, editors. Adverse effects of herbal drugs. Vol. 2. Berlin: Springer-Verlag, 1993:1–90.Google Scholar
  49. 49.
    Woerdenbag HJ. The role and research of phytomedicines in European countries. Ned Tijdschr Fytother. In press.Google Scholar

Copyright information

© Royal Dutch Association for Advancement of Pharmacy 1995

Authors and Affiliations

  • You-Ping Zhu
    • 1
    • 2
  • Herman J. Woerdenbag
    • 3
  1. 1.Foundation Hwa To CentreUniversity of GroningenAV Groningenthe Netherlands
  2. 2.Department of Pharmacognosy, Faculty of PharmacySecond Military Medical UniversityShanghaiPeople's Republic of China
  3. 3.Department of Pharmaceutical BiologyUniversity Centre for Pharmacy, University of GroningenAW Groningenthe Netherlands

Personalised recommendations

Cite article

Buy options